Inspire Investing, LLC Spectrum Pharmaceuticals Inc Transaction History

Inspire Investing, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$2.11 - $3.38 $339 - $544	-161 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$1.83 - $3.45 $37,141 - $70,021	-20,296 Reduced 99.21%	161 $0
Q4 2019 Jan 24, 2020	SELL	$3.5 - $10.35 $3,248 - $9,604	-928 Reduced 4.34%	20,457 $74,000
Q3 2019 Nov 13, 2019	BUY	$7.03 - $9.7 $5,483 - $7,565	780 Added 3.79%	21,385 $177,000
Q2 2019 Jul 16, 2019	BUY	$7.36 - $11.26 $33,708 - $51,570	4,580 Added 28.58%	20,605 $177,000
Q1 2019 May 16, 2019	BUY	$9.08 - $11.84 $145,507 - $189,736	16,025 New	16,025 $171,000
Q1 2018 Apr 13, 2018	SELL	$16.09 - $23.07 $1,496 - $2,145	-93 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$13.36 - $20.73 $1,242 - $1,927	93	93 $2,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.